Dr. Bernstein is a Board Certified Colon and Rectal Surgeon solely dedicated to the treatment of patients with benign and malignant conditions of the colon, rectum and anus. Dr. Bernstein has an expertise in treating patients with colon and rectal cancer, diverticulitis, inflammatory bowel disease and anorectal conditions such as hemorrhoids, fissures and fistulas. Dr. Bernstein has gained additional expertise in treating functional bowel disorders such as fecal incontinence, constipation and rectal prolapse.

Dr. Bernstein received his General Surgery training at the University of Massachusetts Medical Center in Worcester, Massachusetts from 1989-1994. He then went on to complete a fellowship in Colon and Rectal Surgery at the Cleveland Clinic, Florida. Upon completion of his fellowship Dr. Bernstein joined the Division of Colon and Rectal Surgery at St. Luke’s Roosevelt Hospital where he was Associate Chief of the Division of Colon & Rectal Surgery, Program Director for the Fellowship Training Program in Colon and Rectal Surgery and Director of the Anorectal Physiology Lab and Pelvic Floor Center. Dr. Bernstein is widely published and is academically active at both the local and national levels.

NYU LANGONE MEDICAL CENTER

NYU Langone Medical Center, a world-class, patient-centered, integrated, academic medical center, is one of the nation’s premier centers for excellence in clinical care, biomedical research and medical education. Located in the heart of Manhattan, NYU Langone is composed of four hospitals: Tisch Hospital, its flagship acute care facility; the Hospital for Joint Diseases, one of only five hospitals in the nation dedicated to orthopaedics and rheumatology; Hassenfeld Pediatric Center, a comprehensive pediatric hospital supporting a full array of children’s health services; and the Rusk Institute of Rehabilitation Medicine, the world’s first university-affiliated facility devoted entirely to rehabilitation medicine--plus NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. The medical center’s tri-fold mission to serve, teach and discover is achieved 365 days a year through the seamless integration of a culture devoted to excellence in patient care, education and research.

 Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) (RADIANT-4)

The purpose of this study is to compare the antitumor activity of everolimus plus best supportive care versus placebo plus best supportive care in patients with advanced nonfunctional neuroendocrine tumor of gastrointestinal or lung origin.